Molecular Medicine Israel

Tag: new therapy

Modified Cell Therapy Holds Promise for Rare Autoimmune DisorderSafety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a studyModified Cell Therapy Holds Promise for Rare Autoimmune Disorder

Summary Background Chimeric antigen receptor (CAR) T cells are highly effective in treating haematological malignancies, but associated toxicities and the need for lymphodepletion limit their

Read More »